Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

15. Januar 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1903


	Artikel 1 - 20 / 38049

	Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial. EClinicalMedicine Nomura M, Sakanaka K, Shimizu J, Ohashi S, Katada C, Watanabe A, Amanuma Y, Minashi K, Kato K, Kojima T, Nagashima K, Kim I, Tada H, Nakakura A, Muto M. PMID: 41536941 [PubMed]
	Maximum pharyngeal constriction area: an independent predictor of sarcopenic dysphagia after esophageal cancer surgery. Dis Esophagus Takatsu J, Higaki E, Inada K, Yoshida M, Maeda A, Ito K, Ishihara K, Makino H, Watanabe T, Yamamoto M, Abe T. PMID: 41536141 [PubMed - indexed for MEDLINE]
	Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials. Clin Transl Radiat Oncol Shen J, Ai D, Chen Y, Liu Q, Deng J, Hao S, Zhang X, Zhang J, Zhang Y, Chu L, Sun Y, Zhang Y, Xiang J, Miao L, Chen H, Zhu H, Zhao K. PMID: 41531940 [PubMed]
	Integration of habitat radiomics and traditional radiomic features for predicting pathological complete response in esophageal squamous cell carcinoma following neoadjuvant immunotherapy and chemotherapy: a multicenter comparative study. J Transl Med Xu Z, Lu Y, Zuo F, Ding H, Feng Y, Shen X, Song X, Xia W, Mao Q, Chen B, Li R, Wang H, Xu L, Dong G, Jiang F. PMID: 41530793 [PubMed - as supplied by publisher]
	A prognostic nomogram for elderly patients with inoperable esophageal cancer undergoing intensity-modulated radiotherapy. BMC Cancer Zhang H, Yang Y, Li R, Bai X, Li X, Yan X, Song J. PMID: 41530707 [PubMed - as supplied by publisher]
	Comprehensive metabolic profiling uncovers early variation and biomarkers of esophageal squamous cell carcinoma. Sci China Life Sci Shen X, Zhang Y, Wang Q, Li X, Gao M, Li J, Li C, Wang H. PMID: 41530647 [PubMed - as supplied by publisher]
	[Prevalence of Barrett's esophagus and factors associated with the diagnosis of dysplasia or adenocarcinoma in patients evaluated at a Chilean university endoscopy center]. Rev Gastroenterol Peru Espino A, Fuenzalida MJ, Latorre G, Silva F, Corsi O, Palma R, Torres J, Nieto R, Constanzo V, Fuentes G, Nilo M, Salgado L, Vargas C, Vargas JI. PMID: 41530069 [PubMed - indexed for MEDLINE]
	Validation of Methylated DNA Markers for Esophageal Squamous Cancer: An International Study. Cancer Prev Res (Phila) Matchett CL, Slettedahl SW, Taylor WR, Chalmers CE, Foote PH, Berger CK, Mulima G, Tomoka T, Khan S, Mahoney DW, Albert PS, Abnet CC, Dawsey SM, Chen Y, Kisiel JB, Iyer PG. PMID: 41527379 [PubMed - as supplied by publisher]
	Impact of Helicobacter pylori infection on gut and intratumoral microbiome and its association with immunotherapy response in gastrointestinal cancer. BMC Med Jia K, Chen Y, Dai D, Xie Y, Peng H, Cao Y, Zou H, Qiu C, Tan Y, Zhang X, Lu Z, Yin X, Peng Z, Li J, Shen L. PMID: 41526899 [PubMed - as supplied by publisher]
	Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials. J Immunother Cancer Chen B, Chen J, Wang S, Bai K, Li Z, Chen B, Wang R, Cheng X, Gao Y, Yi C, Cen P, Li S, Dragomir MP, Zhu Y, Li Q, Yang H, Xi M. PMID: 41526165 [PubMed - indexed for MEDLINE]
	Association of body composition, tumor-specific assessment, and patient demographics at diagnosis with 90-day and overall survival in esophageal cancer patients in a global population. Dis Esophagus Boshier PR, Gisbertz SS, Hanna GB, Klevebro F, Okamura A, Pramesh CS, Reynolds JV, Rosati R, Skipworth RJE, Tsunoda S, van Hillegersberg R, Weyant M, Wong I, Wood S, van Berge Henegouwen MI, O'Rourke C, Bahnson HT, Low DE. PMID: 41525276 [PubMed - indexed for MEDLINE]
	Baseline dynamic contrast-enhanced magnetic resonance imaging derived parameters and magnetic resonance signal intensity based logistic regression model to predict response of esophageal squamous cell carcinoma to neoadjuvant immunochemotherapy. Dis Esophagus Li JK, Ou J, Su YX, Liao WH, Liao XY, Tan BG, Zhou HY, Li R, Zhang XM, Fu MY, Chen TW. PMID: 41525275 [PubMed - indexed for MEDLINE]
	Evolving diagnostic and surveillance strategies in esophageal cancer screening: Evidence from population-based studies in China. Chin J Cancer Res He Z, Ke Y. PMID: 41523838 [PubMed]
	Development of a predictive model for lymph node metastasis in esophageal cancer using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) semi-quantitative parameters and tumor biomarkers. J Gastrointest Oncol Li N, Huang M, Bao W, Ding C, Mao X. PMID: 41522764 [PubMed]
	Survival analysis of small cell carcinoma of the esophagus: a 15-year retrospective study from a high-incidence region. J Gastrointest Oncol Zhang W, Yuan J, Yang B, Wang J, Chen M. PMID: 41522760 [PubMed]
	Prognostic value of left gastric artery lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma: a retrospective cohort study. J Thorac Dis Yang P, Shi P, Yang T, Liu T, Zhang J, Zhu B, Li Y. PMID: 41522127 [PubMed]
	Association of perioperative cholesterol depletion with anastomotic leak after esophagectomy for cancer: a retrospective study. J Thorac Dis Liu M, He S, Zhou E, Ren B. PMID: 41522112 [PubMed]
	Perioperative outcomes and survival of indocyanine green-guided minimally esophagectomy in patients with esophageal cancer: a retrospective comparison study. Quant Imaging Med Surg Shen X, Cai Y, Xu Z, Yu P, Bhatti MZ, Chen S, Zhan C, Chen T, Zhu H, Zheng L. PMID: 41522083 [PubMed]
	Characteristics, treatment, and outcome of recurrent gastro-oesophageal adeno-carcinoma after perioperative chemotherapy and radical resection. Acta Oncol Larsen AC, Shim S, Bæksgaard L, Pfeiffer P, Nordsmark M, Sørensen JR, Brøndum R, Motavaf AK, Ladekarl M. PMID: 41521569 [PubMed - indexed for MEDLINE]
	Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer. Hum Vaccin Immunother Yan C, He J, Lv G, Gao Y, Li J, Diao R. PMID: 41521567 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 38049

Seite 1 von 1903



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung